Waters Establishes Flagship Innovation and Research Laboratory in Cambridge, MA
September 22 2020 - 7:00AM
Business Wire
Immerse Cambridge unveiled as an open,
collaborative environment designed to accelerate cutting-edge
scientific innovations
Waters Corporation (NYSE:WAT) announced this week at Biotech
Week Boston the establishment of Immerse™ Cambridge, a new Waters'
research laboratory in the heart of Cambridge’s Kendall Square.
Immerse Cambridge will serve as a strategic, collaborative space in
the community, where Waters can partner with academia, research and
industry to accelerate the next generation of scientific
advancements.
This press release features multimedia. View
the full release here:
https://www.businesswire.com/news/home/20200922005364/en/
Inside Immerse Cambridge (Photo: Business
Wire)
“Immerse Cambridge will house the latest analytical instruments
and technology from Waters and will allow us to offer the deep
expertise of our scientists to partner with the biotech community
to innovate, collaborate and interrogate biology in new ways,” said
Dr. Udit Batra, Waters President and CEO. “Waters’ presence in
Kendall Square will enable us to accelerate fresh ideas,
partnerships and opportunities, which encapsulates what Biotech
Week Boston is all about.”
Immerse Cambridge’s open innovation concept features the latest
cutting-edge analytical, informatics and automation tools that
apply to a variety of disciplines across life sciences. The
laboratory is purpose-built for innovation and discovery with both
speed and agility. It is also optimized for disseminating and
expanding ideas through training, joint research and mentoring
experiences for students and up-and-coming industry
professionals.
Waters announced that a cornerstone project at Immerse Cambridge
will feature researchers from both Boston University and Waters
co-developing more effective Influenza A virus vaccines. The
collaboration, aided by the Massachusetts Life Sciences Center,
will harness breakthrough ion mobility-mass spectrometry and
bioinformatics technologies to develop more effective methods and
techniques for measuring protein glycosylation. In the process,
researchers aspire to not only solve a critical problem for
influenza vaccine development, but also establish analytical and
software solutions that will be broadly applicable for the future
of vaccine development and the biomedical field.
In addition to establishing Immerse Cambridge, Waters has
furthered its commitment to the Massachusetts life sciences
community by joining MassBio, a 1,300+ member nonprofit
organization dedicated to preventing, treating and curing diseases
through transformative science and technology that brings value and
hope to patients. This, combined with future plans to expand to a
global network of Immerse labs in major hub cities, will connect
Waters directly to the scientific forefront to improve global human
health and well-being.
“We are thrilled to welcome Waters Corporation to both MassBio
and the Kendall Square community,” said Robert K. Coughlin,
President and CEO, MassBio. “For over 60 years, their analytical
innovations and scientific expertise have made countless
contributions to the global life sciences community, and we look
forward to their expanded presence in the ecosystem working
alongside our members to improve patient lives.”
About Waters Corporation
Waters Corporation (NYSE:WAT), the world's leading specialty
measurement company, has pioneered chromatography, mass
spectrometry, and thermal analysis innovations serving the life,
materials, and food sciences for more than 60 years. With more than
7,000 employees worldwide, Waters operates directly in 35
countries, including 15 manufacturing facilities, and with products
available in more than 100 countries.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20200922005364/en/
Chris Orlando PR Manager, Corporate Communications Waters
Corporation 508-468-9802 Chris_Orlando@Waters.com
Waters (NYSE:WAT)
Historical Stock Chart
From Apr 2024 to May 2024
Waters (NYSE:WAT)
Historical Stock Chart
From May 2023 to May 2024